CYTKbenzinga

Citigroup Maintains Buy on Cytokinetics, Lowers Price Target to $80

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 7, 2025 by benzinga